Cached score snapshot
US.A · Agilent Technologies
110分制 56.4/110;5D動能v2 7/50;排序分 63.4/160
Score breakdown
觀望
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling calibration best | +0.79% | -1.80% / +2.90% | 60% | 0% | Actual outcome pending · 0 / 3 bars observed |
| 30D observation | -0.57% | -5.96% / +3.74% | 42.5% | 30% | Actual outcome pending · 0 / 30 bars observed |
| Historical projection 10D n=160 | +0.81% | -1.19% / +2.71% | 61.9% | 4.4% | Actual outcome pending · 0 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-08-04 → 2026-12-08 · 120 archived points · 2 Improving turn signal · 4 Deteriorating signal · 1 Exit review signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 22 · 資金流 11.6 · 5D動能v2 7
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 3.6/5 · 良好
Sub-items
資金流 — 11.6/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 7.4/15 · 較差
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 6.8/10 · 一般
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 22/30 · 良好
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 3/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 3.6/5分 資金流分析總分: 11.6/20分 市場環境分析總分: 7.4/15分 催化劑分析: 2/20分 風險管理總分: 6.8/10分 技術信號分析總分: 22/30分 情緒分析: 3/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.6,
"details": {
"atrPct": 2.636768120076166,
"turnoverUsdM": 406.84579574218003,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.A",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 168.13,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 1.5,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.3,
"stop_loss_percent": 5.3,
"take_profit_price": 189.1978,
"target_multiplier": 1.9,
"technical_strength": 1.98,
"take_profit_percent": 6.6
},
"positionPoints": 1.6,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.251532121794872,
"stopLossPercent": 5.273536240152332,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 63.4,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 56.4,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 7
},
"market": {
"ma20": 172.0855,
"ma50": 162.54,
"close": 177.49,
"prevClose": 175.96,
"avgVolume20": 2166916,
"volumeRatio": 1.06,
"changePercent": 0.87
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 7,
"details": {
"ret_5d": 0.025894547381192012,
"max_score": 50,
"max_total": 50,
"raw_total": 7,
"vcp_bonus": 0,
"vol_ratio": 1.0636767138670855,
"ret_points": 4,
"vol_points": 2,
"range_ratio": 1.0436224246556207,
"volat_points": 0,
"day_range_pct": 0.028508742548383356,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 1,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 63.4,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 3.6,
"label": "基本面",
"weight": "5/110",
"normalized": 72,
"contribution": 3.6
},
{
"raw": 11.6,
"label": "資金流",
"weight": "20/110",
"normalized": 58,
"contribution": 11.6
},
{
"raw": 7.4,
"label": "市場環境",
"weight": "15/110",
"normalized": 49.33,
"contribution": 7.4
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 6.8,
"label": "風險管理",
"weight": "10/110",
"normalized": 68,
"contribution": 6.8
},
{
"raw": 22,
"label": "技術信號",
"weight": "30/110",
"normalized": 73.33,
"contribution": 22
},
{
"raw": 3,
"label": "情緒分析",
"weight": "10/110",
"normalized": 30,
"contribution": 3
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "觀望",
"result": 56.4,
"details": [
"基本面分析總分: 3.6/5分",
"資金流分析總分: 11.6/20分",
"市場環境分析總分: 7.4/15分",
"催化劑分析: 2/20分",
"風險管理總分: 6.8/10分",
"技術信號分析總分: 22/30分",
"情緒分析: 3/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 3.6,
"資金流": 11.6,
"市場環境": 7.4,
"情緒分析": 3,
"技術信號": 22,
"風險管理": 6.8
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 5,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "良好",
"items": {
"pbPoints": 0.2,
"pePoints": 0.2,
"epsPoints": 0,
"roePoints": 0.75,
"debtPoints": 0.5,
"marginPoints": 0.6,
"turnoverUsdM": 406.84579574218003,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0.3,
"marketCapPoints": 0.5
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 2.4,
"obvPoints": 2.4,
"vwapPoints": 4,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.A",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "較差",
"items": {
"vix": {
"score": 1.8,
"details": {
"source": "twelvedata+fred",
"vixClose": 18.39
}
},
"trend": {
"score": 1.7999999999999998,
"details": {
"qqq": {
"ma20": 733.18400235,
"ma50": 725.2621992000002,
"name": "QQQ",
"close": 721.23999,
"points": 0.4
},
"spy": {
"ma20": 770.4114959000001,
"ma50": 767.5287948999999,
"name": "SPY",
"close": 769.65997,
"points": 1.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 2.636768120076166,
"atrPoints": 3,
"cciPoints": 0.8,
"vixPoints": 1.8,
"marketTrendPoints": 1.7999999999999998
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 3,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 5,
"negativeHits": 0,
"positiveHits": 1,
"sentimentScoreRaw": 0.5
}
},
"sentimentData": {
"raw": [
{
"id": 143022197,
"url": "https://finnhub.io/api/news?id=3ad55fe22e10dbf442c563e643580ea7c6ecd728baf15eb322caeea0425aba95",
"image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
"source": "ChartMill",
"related": "A",
"summary": "Agilent clears the Caviar Cruise quality screen with high ROIC, cash-backed profits, low debt, and forward growth, though valuation is a risk.",
"category": "company",
"datetime": 1792497054,
"headline": "Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow"
},
{
"id": 142820200,
"url": "https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.",
"category": "company",
"datetime": 1791808802,
"headline": "Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"
},
{
"id": 142731215,
"url": "https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...",
"category": "company",
"datetime": 1791479981,
"headline": "Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"
},
{
"id": 142633835,
"url": "https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "A",
"summary": "First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.",
"category": "company",
"datetime": 1791185457,
"headline": "FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"
},
{
"id": 142445426,
"url": "https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...",
"category": "company",
"datetime": 1790489579,
"headline": "Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"
}
],
"raw_source": [
{
"id": 143234638,
"url": "https://finnhub.io/api/news?id=33fd0469ae630f7ea9f3ae4002535a26eb02d001953c63688dc3ae3c0ee967b5",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "SANTA CLARA, Calif. & CHICAGO, October 27, 2026--Agilent Technologies Inc. (NYSE: A), a global leader in analytical and clinical laboratory technologies, and the University of Chicago, one of the world’s leading research universities, today announced a scientific collaboration to establish the Agilent Center of Excellence (CoE) for Energy Materials Research.",
"category": "company",
"datetime": 1793102400,
"headline": "Agilent and University of Chicago Launch Center of Excellence for Energy Materials Research"
},
{
"id": 143210311,
"url": "https://finnhub.io/api/news?id=62c9e537512e6cb978d648e347ec2aa3a50766d750d6f92ee0d52c2445aeb54f",
"image": "",
"source": "Fintel",
"related": "A",
"summary": "",
"category": "company",
"datetime": 1793065761,
"headline": "Deutsche Bank Initiates Coverage of Agilent Technologies at Buy"
},
{
"id": 139762682,
"url": "https://finnhub.io/api/news?id=36ec11a2c407b450f53c7d6f174dfeaa3ae2ddf57e85a2ecae63910222992539",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls",
"category": "company",
"datetime": 1793022131,
"headline": "Tesla upgraded, AppLovin initiated: Wall Street's top analyst calls"
},
{
"id": 143190207,
"url": "https://finnhub.io/api/news?id=323c51ff55e42e4c75789b502cab9ae59fe8e5737e4acd79195dab1edd735b7a",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1484319196/image_1484319196.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "A",
"summary": "Greenlight Capital questions the market valuations and TAM claims of AI providers in Q3 2026. Read the full analysis for more details.",
"category": "company",
"datetime": 1792984200,
"headline": "How Can Investors Have Confidence In The Terminal Value Of The Large AI Providers"
},
{
"id": 143143733,
"url": "https://finnhub.io/api/news?id=1bf25eff3f4e92d5e3da84b6ae1d3b3cef34fe9794d5c4985be63bc283f867aa",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "A",
"summary": "Get a weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers, including dividend changes and key ex-dividend dates.",
"category": "company",
"datetime": 1792793778,
"headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 25"
},
{
"id": 143136290,
"url": "https://finnhub.io/api/news?id=324ee5b3a38ddfccd02201049082a470e6a07e75ff50bef2f94295ef71da456f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "For questions about this article or underlying research, email help@trefis.com.",
"category": "company",
"datetime": 1792777012,
"headline": "Should Illumina Stock Holders Look At Thermo Fisher Instead?"
},
{
"id": 143103807,
"url": "https://finnhub.io/api/news?id=5c21fa63cd35232d2c5c26ebbabd64de5cc15b4566bd5be00d4e058a6c9a0e26",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Quest Diagnostics beats Q3 earnings and revenue estimates, raises its 2026 outlook on strong testing demand and margin gains, yet shares dip in pre-market trading.",
"category": "company",
"datetime": 1792689420,
"headline": "DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market"
},
{
"id": 143067518,
"url": "https://finnhub.io/api/news?id=794e1cfd80211130a51f49c289e590f333c24975e2283abfa22c1d3c8c1ea221",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Abbott's Q3 earnings miss weighs on its stock despite double-digit revenue growth and expanding margins, while lower 2026 sales guidance raises concerns.",
"category": "company",
"datetime": 1792585740,
"headline": "ABT Stock Down Post Q3 Earnings Miss, Revenues Rise Y/Y, Margins Up"
},
{
"id": 143053238,
"url": "https://finnhub.io/api/news?id=b3240d35fc726ac96d2a46990b129fdd96cab575deeba691835f9ad5f7890c5d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Dublin, Oct. 21, 2026 (GLOBE NEWSWIRE) -- \"Bioconjugation Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global bioconjugation market is experiencing rapid growth, supported by expanding biologics research, increased development of antibody-based therapeutics, and rising demand for advanced diagnostic assays. The market is projected to grow from $6.12 billion in 2025 to $6.89 billion in 2026, representing a compound annual growth rate (CAGR) of 12.5%. Growth during",
"category": "company",
"datetime": 1792570260,
"headline": "Bioconjugation Market Report 2026: Global Size, Share, Trends and 2030 Forecast | Capitalize on Targeted Therapeutics | Thermo Fisher, Merck, Danaher, Lonza, and Agilent Lead the Industry"
},
{
"id": 143028934,
"url": "https://finnhub.io/api/news?id=42fb19fac55354e2499a0acbf2bc8308b27df6ce408c5e6156e04c9f73a7e9cc",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "WAT's AI Link launch and Anthropic collaboration aim to automate LC-MS workflows, streamline lab operations and drive instrument demand.",
"category": "company",
"datetime": 1792502400,
"headline": "Waters Launches AI Link to Advance AI-Enabled LC-MS Workflows"
},
{
"id": 143022197,
"url": "https://finnhub.io/api/news?id=3ad55fe22e10dbf442c563e643580ea7c6ecd728baf15eb322caeea0425aba95",
"image": "https://www.chartmill.com/images/uploads/thumbnail_article_luc_kroeze_c1f44c837d.webp",
"source": "ChartMill",
"related": "A",
"summary": "Agilent clears the Caviar Cruise quality screen with high ROIC, cash-backed profits, low debt, and forward growth, though valuation is a risk.",
"category": "company",
"datetime": 1792497054,
"headline": "Agilent Technologies (NYSE:A) Stands Out as a Quality Stock on Strong Returns and Cash Flow"
},
{
"id": 143008103,
"url": "https://finnhub.io/api/news?id=6a0037dab5aeaac2a085732688934dea1356ae0238c2f50d89765d291f02fdd6",
"image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_1.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "A",
"summary": "Agilent Technologies (NYSE:A) has outperformed the market over the past 10 years by 1.17% on an annualized basis producing an average annual return of 14.8%. Currently, Agilent Technologies has a market capitalization",
"category": "company",
"datetime": 1792406743,
"headline": "$1000 Invested In Agilent Technologies 10 Years Ago Would Be Worth This Much Today"
},
{
"id": 142962673,
"url": "https://finnhub.io/api/news?id=dd52dba685ab595cdbabab40302073ceebfd41def3e89be68d2df27a6913cf58",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "After three decades climbing to the top of one of Wall Street's most powerful firms, a single executive held millions of shares in the company he had given his career to. Then came the week that changed everything.",
"category": "company",
"datetime": 1792254678,
"headline": "In 2008, After 34 Years Working For The Same Company, He Owned More Than 6 Million Shares Of Company Stock. Eight Months Later, The Company Was Bankrupt and The Shares Were Nearly Worthless. The Story Of Joe Gregory Holds An Important Lesson For Every Investor"
},
{
"id": 142946380,
"url": "https://finnhub.io/api/news?id=8fff397571c718c07e445c7fb238c74aa0e31d5c1fbf64085e069e8d4530064e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial performance.",
"category": "company",
"datetime": 1792159899,
"headline": "1 Surging Healthcare Stock Worth Your Attention and 2 We Turn Down"
},
{
"id": 142940598,
"url": "https://finnhub.io/api/news?id=262b21b1adc1b71fef9fe843b9b682d06e5d7329d37b36a536b81ad53e181907",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, Customer and CountryDublin, Oct. 16, 2026 (GLOBE NEWSWIRE) -- \"Immuno-Oncology Diagnostics. Market Forecasts for Immuno-Oncology Diagnostics by Assay Type, Technology, Client, and Country with Executive/Consultant Guides 2026 to 2030 (4th Edition)\" has been added to ResearchAndMarkets.com's offering. The report highlights the continued expansion of",
"category": "company",
"datetime": 1792143780,
"headline": "Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests"
},
{
"id": 142880640,
"url": "https://finnhub.io/api/news?id=f59fb84a1dddc2400f63f414be29dad3e7429ba4db920560f5af7615a7d1d9b4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.",
"category": "company",
"datetime": 1791976316,
"headline": "Agilent acquires Proscia in deal worth up to $270m"
},
{
"id": 142884529,
"url": "https://finnhub.io/api/news?id=c5802bcda140f286c39d247fed77151eb14a83c236706ed9d72001d98e550db9",
"image": "https://cdn.benzinga.com/files/images/story/2026/10/14/Business-Mergers-And-Acquisitions-Concep.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "A",
"summary": "Agilent (A) to acquire Proscia for up to $270M to expand AI-powered digital pathology & diagnostic capabilities. Stock edges higher.",
"category": "company",
"datetime": 1791969631,
"headline": "Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist"
},
{
"id": 142872383,
"url": "https://finnhub.io/api/news?id=f787c7b9b42d55a03cd4a0b6dcda8b2030c5da929b0fc2afc9f13417433f89b2",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and regional presence.Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- \"Metabolomics Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global metabolomics market is experiencing rapid expansion, driven by advances in biomarker discovery, personalized medicine, cancer research and analytical technologies. The market grew from $4.17 bil",
"category": "company",
"datetime": 1791965160,
"headline": "Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics"
},
{
"id": 142885464,
"url": "https://finnhub.io/api/news?id=ca55eb1d7732b96a5721dd224220baa4cbf255435598a2e7e851fcfae6a23d8d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.",
"category": "company",
"datetime": 1791959378,
"headline": "Agilent to buy Proscia for $240M"
},
{
"id": 142849053,
"url": "https://finnhub.io/api/news?id=6fc26925705f3d72cf48b269551fa1c08ea36bb23b3f1ba47d48926b51183b6e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "SANTA CLARA, Calif. & PHILADELPHIA, October 13, 2026--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, in an all-cash transaction valued at $240 million in cash at closing and up to an additional $30 million based on achieving future performance milestones.",
"category": "company",
"datetime": 1791892800,
"headline": "Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence"
},
{
"id": 142884530,
"url": "https://finnhub.io/api/news?id=c1b0d7a8d698fe1997b21a865b7d9783823b5719b16985faf0da984950fc4655",
"image": "",
"source": "Benzinga",
"related": "A",
"summary": "TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $180 to $196.",
"category": "company",
"datetime": 1791891562,
"headline": "TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196"
},
{
"id": 142884531,
"url": "https://finnhub.io/api/news?id=9b35f2007459e45e29c82c9aa6d0e52a64c4e923f02492cd7953b9ea18d2b71a",
"image": "",
"source": "Benzinga",
"related": "A",
"summary": "Morgan Stanley analyst Kallum Titchmarsh maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $190.",
"category": "company",
"datetime": 1791891494,
"headline": "Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190"
},
{
"id": 142839262,
"url": "https://finnhub.io/api/news?id=d2236c8c28c291f8d06435628151897272438e2c76e2f409c8bed47f16e3d589",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- \"Chromosomal Microarray Reflex Testing Global Market Report 2026\" has been added to ResearchAndMarkets.com's offering. The global chromosomal microarray reflex testing market is experiencing strong growth as healthcare providers increase their use of advanced genomic diagnostics for prenatal, postnatal, oncology, and rare disease applications. The market is projected to grow from $1.39 billion in 2025 to $1.51 billion in 2026, representing a compound ann",
"category": "company",
"datetime": 1791878580,
"headline": "Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics"
},
{
"id": 142820200,
"url": "https://finnhub.io/api/news?id=e5b5228a892afb854995ba185b865f6af7d31e47c95767cdc2d37e77e167926f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.",
"category": "company",
"datetime": 1791808802,
"headline": "Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?"
},
{
"id": 142731215,
"url": "https://finnhub.io/api/news?id=b9ad7f7c83f68f77f768b32672fe150f58440903e569bbc9921aca0b44bb676c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Agilent Technologies has delivered a solid share price run over recent years, and the question now is whether the current valuation is properly backed by the cash the business can generate. With fresh investment in new labs and instruments on the table, investors are asking how those projects feed into the stock's intrinsic value based on its cash flows. Over the past 3 years the stock has returned 52.5%, which puts real weight on whether cash generation can support the price that move has...",
"category": "company",
"datetime": 1791479981,
"headline": "Is Agilent Technologies (A) Cheap Enough To Justify Its Cash Flow?"
},
{
"id": 142695688,
"url": "https://finnhub.io/api/news?id=54b2461c864239e33dfabc7a5f3aa6a8062696dfa72aec15a19b4970dde3fecc",
"image": "",
"source": "Benzinga",
"related": "A",
"summary": "Barclays analyst Luke Sergott maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $195.",
"category": "company",
"datetime": 1791365165,
"headline": "Barclays Maintains Overweight on Agilent Technologies, Raises Price Target to $195"
},
{
"id": 142647609,
"url": "https://finnhub.io/api/news?id=c842fcc48355b415ae781153021086982bc5ef2315cf2c17223cf25039995173",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2163482326/image_2163482326.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "A",
"summary": "Technology was the only sector to gain in September as mega-cap strength masked broad market weakness. Read more here.",
"category": "company",
"datetime": 1791250200,
"headline": "Moat Stocks Retreat As Market Breadth Narrows"
},
{
"id": 142633835,
"url": "https://finnhub.io/api/news?id=2eb8408fc2372f0d7df88dbbc9133e3a1155d872cc69ffa7774a7678864fa389",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2276411485/image_2276411485.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "A",
"summary": "First Trust Water ETF keeps underperforming the broader market, implying that there's more to consider than just demand. I rate the FIW ETF as Sell. Click to read my analysis.",
"category": "company",
"datetime": 1791185457,
"headline": "FIW: Massive Water Infrastructure Needs Aren't Enough To Justify A Buy"
},
{
"id": 142593872,
"url": "https://finnhub.io/api/news?id=499bf9bb38b2e7b37ffd4baa210386aa2765fea7f5aabdb08f96d7dabdf7322d",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "A",
"summary": "Track weekly dividend updates for Dividend Champions, Contenders & Challengersâsee dividend changes, upcoming ex-dividend and pay dates. Read it here.",
"category": "company",
"datetime": 1790965134,
"headline": "Dividend Champion, Contender, And Challenger Highlights: Week October 4"
},
{
"id": 142559868,
"url": "https://finnhub.io/api/news?id=8b175ceb5b7bff39983b76422ee597a0905fad70b8d2ff3eeb3a31a160e63ea4",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
"category": "company",
"datetime": 1790865004,
"headline": "Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?"
},
{
"id": 142588193,
"url": "https://finnhub.io/api/news?id=309bd205640725159056e0eb9ab31f49a57990c5d5ed2d0ca8a7b06b3613fb67",
"image": "https://cdn.benzinga.com/files/images/story/2025/07/10/valuestock_3.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "A",
"summary": "Agilent Technologies (NYSE:A) has outperformed the market over the past 15 years by 1.05% on an annualized basis producing an average annual return of 14.43%. Currently, Agilent Technologies has a market capitalization",
"category": "company",
"datetime": 1790858747,
"headline": "$1000 Invested In Agilent Technologies 15 Years Ago Would Be Worth This Much Today"
},
{
"id": 142557959,
"url": "https://finnhub.io/api/news?id=8a17cf1a74d2ef0a8e32e203d206f2395bdb550fe0f0e12abcf88e004c2922dc",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "SANTA CLARA, Calif., October 01, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time",
"category": "company",
"datetime": 1790856000,
"headline": "Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows"
},
{
"id": 142496160,
"url": "https://finnhub.io/api/news?id=ef18193aa55d6b8032d176e715ec487656be230854007991936e0d42bbb488e7",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.",
"category": "company",
"datetime": 1790683200,
"headline": "Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers"
},
{
"id": 142463307,
"url": "https://finnhub.io/api/news?id=2a2c59b622ef2cae5b0b5c0f8089761a5aa4c5cfac4ea08d75d8dc51e8bbe26b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 46.9% gain over the past six months, beating the S&P 500 by 25.5 percentage points.",
"category": "company",
"datetime": 1790587116,
"headline": "3 Healthcare Stocks That Fall Short"
},
{
"id": 142445426,
"url": "https://finnhub.io/api/news?id=9c786dfccd5c711947457a233c7a6a55226c5e0c02b2d5e54c9a5e36229e194e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "A",
"summary": "Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...",
"category": "company",
"datetime": 1790489579,
"headline": "Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 5,
"negative_hits": 0,
"positive_hits": 1,
"recomputed_at_score": true,
"sentiment_score_raw": 0.5,
"source_article_count": 35,
"discarded_article_count": 30
},
"sentimentPoints": 3
}
},
"技術信號": {
"max": 30,
"raw": 22,
"grade": "良好",
"items": {
"bbPoints": 3,
"adxPoints": 3,
"sarPoints": 2.4000000000000004,
"vcpPoints": 1.6,
"macdPoints": 2.4,
"vcpPayload": {
"vcp_pass": false,
"vcp_score": 1.6,
"vcp_reason": "波幅收縮(18.1%→5.4%);站上MA50;Ready=N;Confirm=N",
"vcp_metrics": {
"up_days": 5,
"vol_ref": 2419750,
"down_days": 4,
"vcp_ready": false,
"above_ma50": true,
"avg_vol_10": 2141540,
"avg_vol_20": 2154995,
"avg_vol_30": 2419750,
"range_pct_10": 0.05358053672992634,
"range_pct_20": 0.08890641225385024,
"range_pct_30": 0.1808553056028336,
"up_expand_ok": false,
"lookback_used": 59,
"near_20d_high": true,
"contraction_ok": true,
"down_shrink_ok": false,
"up_expand_days": 0,
"breakout_20d_ok": false,
"vol_ratio_10_30": 0.8850253125322864,
"dist_to_20d_high": 0.008989390899531415,
"down_shrink_days": 1,
"breakout_level_20d": 179.10001,
"vcp_breakout_confirm": false,
"contraction_ratio_10_30": 0.29626190147604303
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": true
},
"kdjAdxPoints": 0.8,
"rsiKdjPoints": 4,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 1,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0.6,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "一般",
"items": {
"position": {
"score": 1.6,
"details": {
"atrPct": 2.636768120076166,
"turnoverUsdM": 406.84579574218003,
"liquidityPoints": 0.6,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.A",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 168.13,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 3,
"macd_score": 1.5,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.3,
"stop_loss_percent": 5.3,
"take_profit_price": 189.1978,
"target_multiplier": 1.9,
"technical_strength": 1.98,
"take_profit_percent": 6.6
},
"positionPoints": 1.6,
"stopLossPoints": 1.8,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.251532121794872,
"stopLossPercent": 5.273536240152332,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 85.71,
"atr": {
"atr": 4.68,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.64
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": 135.27
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.0207
},
"kdj": {
"d": 63.66,
"j": 74.45,
"k": 67.25,
"rule": "Cursor_18.24 K/D cross",
"score": 6,
"signal": "強金叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "平衡",
"score": 6,
"value": 57.85
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 6,
"trend": "有流入",
"value": 20186018,
"recentSlope": 21971.8,
"previousSlope": 108780
},
"rsi": 63.59,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 8,
"trend": "上升",
"value": 168.8795,
"position": "SAR喺價下",
"distancePct": 4.85,
"previousTrend": "上升"
},
"ma50": 162.54,
"macd": {
"macd": 3.7826201211356647,
"trend": "中性偏多",
"signal": 4.035522028288078,
"histogram": -0.25290190715241323
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 10,
"value": 172.0615,
"position": "連續5日>VWAP",
"consecutiveAbove": 6
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 1.06,
"score": 6,
"avgVolume": 2166916,
"currentVolume": 2292218
},
"derived": {
"ma20": 172.0855,
"ma50": 162.54,
"prevClose": 175.96,
"avgVolume10": 2217092,
"avgVolume20": 2166916,
"changePercent": 0.87,
"avgVolumeForScore": 2166916
},
"ma_cross": {
"ma20": 172.0855,
"ma50": 162.54,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 171.9625,
"prevMa50": 161.9592,
"spreadPct": 5.87,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 165.9839,
"upper": 178.1871,
"position": "上半部"
},
"rsi_short": 72.39,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 1.06
}
}
}
Raw metrics JSON
{
"close": 177.49,
"volume": 2292218,
"changePercent": 0.87
}
Scores are derived from cached daily market data using the Solorank 110-point standard. Solorank provides research support only and does not provide financial advice or buy/sell recommendations.